Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Avidity Biosciences Appoints President and CEO | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Avidity Biosciences Appoints President and CEO

Sarah Boyce brings extensive experience in the life sciences industry

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Avidity Biosciences has appointed Sarah Boyce as President and Chief Executive Officer and a member of the Avidity Board of Directors.
 
“We are delighted to welcome Sarah as the new CEO of Avidity Biosciences,” said Troy Wilson, Ph.D., J.D., Executive Chairman of the Board of Directors, co-founder and founding CEO of Avidity. “Sarah’s broad experience in the healthcare industry, combined with her strategic expertise and track record of leading high-performance teams, position her to be a great partner to both the board and management as we continue to advance our pipeline, optimize our AOC™ platform and prepare to initiate our first clinical study.”
 
Ms. Boyce has extensive experience in the life sciences industry, where she has built global organizations and brought to patients a number of innovative therapies, including Tegsedi, Waylivra, Soliris, Gleevec and Tasigna. She most recently served as President and a member of the board of directors of Akcea Therapeutics, where she led commercialization of the company’s rare disease products. Prior to joining Akcea in April 2018, Ms. Boyce held multiple executive-level roles at leading pharma and biotech companies including Ionis Pharmaceuticals, Forest Laboratories, Alexion Pharmaceuticals, Novartis Oncology and Roche.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters